Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0579-z

Related search